Interventional Neuroradiology Market Scope And Analysis

  • Report Code : TIPRE00003497
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Interventional Neuroradiology Market Analysis, Scope, and Growth by 2031

Buy Now


Interventional Neuroradiology Market Report Scope

Report Attribute Details
Market size in 2023 US$ 4.42 Billion
Market Size by 2031 US$ 2.41 Billion
Global CAGR (2023 - 2031) 7.2%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Neurovascular Embolization & Coiling Assist Devices
  • Accessories
By Disease
  • Cerebral Aneurysms
  • Intra-Cranial Tumors
  • Acute Strokes
  • Other Diseases
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • BALT EXTRUSION
  • Terumo Corporation
  • Merit Medical Systems
  • Medtronic
  • Penumbra Inc
  • Stryker
  • DePuy Synthes
  • W L Gore Associates
  • Boston Scientific Corporation
  • MicroPort Scientific Corporation
  •  Interventional Neuroradiology Market News and Recent Developments

    The  Interventional Neuroradiology Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the  interventional neuroradiology market are listed below:

    • Royal Philips, a global leader in health technology, announced major enhancements to its Image Guided Therapy System – Azurion – with the launch of its new Azurion neuro biplane system. (Source: Royal Philips, Company Website, February 2024)
    • CERENOVUS, Inc., part of Johnson & Johnson MedTech, launched CEREGLIDE 71 Intermediate Catheter, a next-generation intermediate catheter with TruCourse indicated for the revascularization of patients suffering from acute ischemic stroke. (Source: CERENOVUS, Inc., Company Website, February 2024)

     Interventional Neuroradiology Market Report Coverage and Deliverables

    The “ Interventional Neuroradiology Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Interventional neuroradiology market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Interventional neuroradiology market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Interventional neuroradiology market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the XYZ market
    • Detailed company profiles